Add‐on effect of PSORI‐CM01 to topical calcipotriol for moderate psoriasis vulgaris: A multi‐center, randomized, double‐blind pilot study-Reference-Cited by-同舟云学术

Add‐on effect of PSORI‐CM01 to topical calcipotriol for moderate psoriasis vulgaris: A multi‐center, randomized, double‐blind pilot study

Published:2021-01 Issue:1 Volume:11 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Parker Shefton¹,Zhang Anthony Lin¹,Zhang Claire Shuiqing¹^ORCID,Goodman Greg²,Wen Zehuai¹³⁴,Yan Yuhong³⁴,Yao Danni³⁴,Wu Huimei³⁴,Deng Hao³⁴,Lu Chuanjian¹³⁴⁵,Xue Charlie Changli¹³⁴⁵

Affiliation:

1. China‐Australia International Research Centre for Chinese Medicine School of Health and Biomedical Sciences RMIT University Bundoora Victoria Australia

2. The Dermatological Institute of Victoria South Yarra Victoria Australia

3. Guangdong Provincial Hospital of Chinese Medicine Guangzhou China

4. Guangdong Provincial Academy of Chinese Medical Sciences Guangzhou China

5. The Second Clinical College Guangzhou University of Chinese Medicine Guangzhou China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.286

Reference30 articles.

1. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics